M
Magnolia Clinical Research, LLC. | Cary, NC
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
ACP-211
SP-624
Azetukalner
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of...
Enrolling
Major Depressive Disorder
Drug: Azetukalner
Drug: Placebo
This is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depr...
Active, not recruiting
Major Depressive Disorder
Drug: SP-624
Drug: Placebo
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response (NORLIGHT)
The goal of this clinical trial is to learn if ACP-211 can help treat adults with major depressive disorder (MDD) who have not improved with antidepr...
Enrolling
Depressive Disorder, Treatment-Resistant
Major Depressive Disorder (MDD)
Drug: ACP-211
Drug: Placebo
Trial sponsors
S
X
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems